New vaccine boosts India's bid to become low-cost lab of the world
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
New Delhi
INDIA has long been known as a country that knows how to reproduce generic versions of patented drugs at lower cost.
This week it broke new ground when it unveiled the first indigenously developed vaccine against a diarrhoea-causing virus that is one of the leading causes of early childhood deaths around the world.
Share with us your feedback on BT's products and services
TRENDING NOW
Japan stocks look set for new highs in 2025 on earnings, reform
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
